Development of a Recombinant Protein Vaccine Based on Cell-Free Protein Synthesis for Sevenband Grouper Epinephelus septemfasciatus Against Viral Nervous Necrosis

J Microbiol Biotechnol. 2015 Oct;25(10):1761-7. doi: 10.4014/jmb.1507.07004.

Abstract

Sevenband grouper, Epinephelus septemfasciatus, is becoming an important aquaculture species in Korea. However, viral nervous necrosis disease is a large problem causing mass mortality in sevenband grouper aquaculture. Recombinant protein vaccines are one of the best methods to reduce these economic losses. However, the cell-based expression method mainly produces inclusion bodies and requires additional procedures. In this study, we expressed a recombinant viral coat protein of sevenband grouper nervous necrosis virus (NNV) using a cell-free protein synthesis system. The purified recombinant NNV coat protein (rNNV-CP) was injected into sevenband grouper at different doses followed by a NNV challenge. Nonimmunized fish in the first trial (20 μg/fish) began to die 5 days post-challenge and reached 70% cumulative mortality. In contrast, immunized fish also starting dying 5 days postchallenge but lower cumulative mortality (10%) was observed. Cumulative morality in the second trial with different doses (20, 4, and 0.8 μg/fish) was 10%, 40%, and 50%, respectively. These results suggest that rNNV-CP can effectively immunize sevenband grouper depending on the dose administered. This study provides a new approach to develop a recombinant vaccine against NNV infection for sevenband grouper.

Keywords: cell free protein synthesis (CFPS); nervous necrosis virus (NNV); recombinant protein; sevenband grouper; viral nervous necrosis (VNN).

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Bass*
  • Capsid Proteins / genetics
  • Capsid Proteins / immunology*
  • Fish Diseases / prevention & control*
  • Korea
  • Nodaviridae / genetics
  • Nodaviridae / immunology*
  • Recombinant Proteins / genetics
  • Recombinant Proteins / immunology
  • Survival Analysis
  • Treatment Outcome
  • Vaccines, Synthetic / administration & dosage
  • Vaccines, Synthetic / genetics
  • Vaccines, Synthetic / immunology
  • Viral Vaccines / administration & dosage
  • Viral Vaccines / genetics
  • Viral Vaccines / immunology*
  • Virus Diseases / prevention & control
  • Virus Diseases / veterinary*

Substances

  • Capsid Proteins
  • Recombinant Proteins
  • Vaccines, Synthetic
  • Viral Vaccines